Members from the state’s board of medicine and osteopathic medicine voted in favor of sending the controversial rule — which would likely bar puberty blockers, hormone replacement therapy as well as surgical interventions, which are extremely rare, as a treatment for gender dysphoria in minors — to the full boards on Nov. 4.